Table 4.
Author | Surgical domain—wound dehiscence and/or wound infection | Variables of significance listed as a risk factor, statistical analysis method used (P value where reported) |
---|---|---|
McDonald et al. 69 | Cardiothoracic surgery—median sternotomy infection and dehiscence | Multivariate analysis: female gender (P = 0·03), obesity (P = 0·002), diabetes (P = 0·01) and prolonged postoperative ventilation (P = 0·006) |
Webster et al. 2, * | Abdominal surgery—abdominal wound dehiscence | Logistic regression P < 0·05, COPD (0·002), postgraduate year of surgeon (PGY4) (0·003), operative time (0·013), emergency procedure (<0·0001), clean wound classification (0·0031), superficial wound infection (0·0048), deep wound infection (<0·0001), failure to wean from ventilator (<0·0001) and current pneumonia (0·04) |
Baskett et al. 43 | Cardiothoracic surgery—surgical wound infection | COPD (0·01) |
Borger et al. 70 | Cardiothoracic surgery—deep sternal wound infection | Diabetes, male, bilateral internal thoracic artery grafting maybe contraindicated in diabetic patients |
Paletta et al. 71 | Vascular surgery—leg complications | Multivariate analysis: female gender (0·001) and peripheral vascular disease (0·001) |
Ridderstolpe et al. 6 | Cardiothoracic surgery—superficial and deep sternal wound complications | Superficial wound complications: univariate with ROC analysis: age ≥ 65 (P = 0·006), age ≥ 75 (P = 0·020), BMI ≥ 30 (P = 0·001), diabetes (P = 0·008), ventilator support (P = 0·008). Deep sternal infections/mediastinitis: BMI ≥ 30 (P = 0·001), diabetes (P = 0·001), smoking (P = 0·001), COPD (P = 0·001), PVD (P = 0·001), reoperation—bleeding (P = 0·08), red blood cells—units (P = 0·02) and ventilator support (P = 0·004) |
Salehi Omran et al. 49 | Cardiothoracic surgery—superficial and deep sternal wound infection following CABG | Multivariate analysis: female gender (<0·05), preoperative hypertension (<0·05), diabetes (0·05), obesity (0·05), prolonged intubation time (>48 hours) (0·05), re‐exploration for bleeding (<0·05) and hypertension (<0·05) |
Schimmer et al. 46 | Cardiothoracic surgery—sternal dehiscence and infection | Odds ratio, P value: body mass indices greater than 30 kg/m2 (P = 0·05), New York Heart Association class more than III (P = 0·07), impaired renal function (P = 0·07), peripheral arterial disease (P = 0·001), immunosuppressant state (P = 0·001), sternal closure performed by an assistant doctor (P = 0·004), postoperative bleeding (P = 0·03), transfusion of more than 5 red blood cell units (P = 0·03), re‐exploration for bleeding (P = 0·001) and postoperative delirium (P = 0·01) |
Sharma et al. 45 | Vascular surgery—leg complications | Forward stepwise logistic regression: female gender (0·008), renal insufficiency (<0·001), diabetes (<0·001), BMI ≥ 30 kg/m2 (<0·001), peripheral vascular disease (0·09) and ICU stay < 72 hours (0·009) |
van Ramshorst et al. 1, * | Abdominal surgery—abdominal wound dehiscence | Multivariate stepwise logistic regression with backwards elimination, P < 0·05, age overall P value (0·02), male gender (<0·001), ascites (<0·01), wound infection (<0·001), emergency surgery (0·001), CPD (<0·001), type of surgery overall P value (0·001) and coughing (<0·001) |
Floros et al. 44 | Cardiothoracic surgery—deep sternal wound infection | Fisher's exact test P value (<0·05), previous cardiac surgery (0·03), BMI ≥ 30 (0·041), left ventricular ejection fraction (LVEF) ≤ 30 (0·01) and homologous blood usage (<0·01) |
BMI, body mass index; CABG, coronary artery bypass graft; SWD, surgical wound dehiscence.
Risk tool/prognostic models tested.